MNX1 and breast cancer: In this study, integrated bioinformatics analysis and clinical tissue sample examinations revealed that MNX1-AS1 expression is significantly upregulated in BC tissues compared to normal controls, and this overexpression correlates strongly with poor clinical outcomes.